nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Terazosin—ABCB1—adrenal gland cancer	0.201	0.412	CrCbGaD
Alfuzosin—Doxazosin—ABCB1—adrenal gland cancer	0.15	0.306	CrCbGaD
Alfuzosin—Prazosin—ABCB1—adrenal gland cancer	0.138	0.282	CrCbGaD
Alfuzosin—KCNH2—Potassium Channels—KCNJ5—adrenal gland cancer	0.0288	0.0563	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Other—GNRHR—adrenal gland cancer	0.0222	0.0434	CbGpPWpGaD
Alfuzosin—ADRA1D—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0149	0.0292	CbGpPWpGaD
Alfuzosin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0138	0.027	CbGpPWpGaD
Alfuzosin—KCNH2—Neuronal System—KCNJ5—adrenal gland cancer	0.0126	0.0246	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0125	0.0244	CbGpPWpGaD
Alfuzosin—ADRA1B—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0124	0.0243	CbGpPWpGaD
Alfuzosin—ADRA1A—Endothelin Pathways—GNAS—adrenal gland cancer	0.0114	0.0223	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0111	0.0218	CbGpPWpGaD
Alfuzosin—ADRA1A—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.011	0.0215	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0103	0.0202	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00925	0.0181	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00919	0.018	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (12/13) signalling events—CDC42—adrenal gland cancer	0.00841	0.0165	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00825	0.0161	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00822	0.0161	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00767	0.015	CbGpPWpGaD
Alfuzosin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00755	0.0148	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00747	0.0146	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (12/13) signalling events—CDC42—adrenal gland cancer	0.00698	0.0137	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00685	0.0134	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00668	0.0131	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00629	0.0123	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (12/13) signalling events—CDC42—adrenal gland cancer	0.0062	0.0121	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0062	0.0121	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00609	0.0119	CbGpPWpGaD
Alfuzosin—ADRA1D—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00573	0.0112	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00554	0.0108	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0055	0.0108	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00522	0.0102	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00494	0.00967	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00492	0.00963	CbGpPWpGaD
Alfuzosin—KCNH2—Neuronal System—PRKACA—adrenal gland cancer	0.00482	0.00942	CbGpPWpGaD
Alfuzosin—ADRA1B—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00475	0.00929	CbGpPWpGaD
Alfuzosin—ADRA1D—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00464	0.00908	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00463	0.00906	CbGpPWpGaD
Alfuzosin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00455	0.0089	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00441	0.00862	CbGpPWpGaD
Alfuzosin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00434	0.00848	CbGpPWpGaD
Alfuzosin—ADRA1A—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00422	0.00826	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0041	0.00802	CbGpPWpGaD
Alfuzosin—ADRA1B—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00385	0.00753	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00377	0.00736	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00366	0.00715	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00365	0.00713	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00355	0.00694	CbGpPWpGaD
Alfuzosin—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00342	0.00669	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—TSHR—adrenal gland cancer	0.00336	0.00656	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00325	0.00635	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00323	0.00631	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00313	0.00611	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00299	0.00584	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00295	0.00576	CbGpPWpGaD
Alfuzosin—ADRA1B—LPA receptor mediated events—EGFR—adrenal gland cancer	0.00288	0.00564	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—TSHR—adrenal gland cancer	0.00279	0.00545	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00278	0.00543	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00268	0.00523	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00262	0.00512	CbGpPWpGaD
Alfuzosin—KCNH2—Neuronal System—BRAF—adrenal gland cancer	0.0026	0.00508	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00247	0.00484	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00238	0.00465	CbGpPWpGaD
Alfuzosin—ADRA1B—AMPK Signaling—TP53—adrenal gland cancer	0.00228	0.00446	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00213	0.00416	CbGpPWpGaD
Alfuzosin—ADRA1A—AMPK Signaling—TP53—adrenal gland cancer	0.00203	0.00396	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—GNAS—adrenal gland cancer	0.00195	0.00382	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00193	0.00378	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GNRHR—adrenal gland cancer	0.00191	0.00373	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0019	0.00371	CbGpPWpGaD
Alfuzosin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00189	0.00369	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00177	0.00346	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00177	0.00345	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00173	0.00337	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—TSHR—adrenal gland cancer	0.00172	0.00337	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00167	0.00326	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—GNAS—adrenal gland cancer	0.00162	0.00317	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0016	0.00314	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GNRHR—adrenal gland cancer	0.00158	0.00309	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00157	0.00308	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00157	0.00307	CbGpPWpGaD
Alfuzosin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00153	0.00299	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00147	0.00287	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00144	0.00281	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00143	0.0028	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00143	0.00279	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00142	0.00279	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.0014	0.00275	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0014	0.00273	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00138	0.0027	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00132	0.00258	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—POMC—adrenal gland cancer	0.00131	0.00257	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00131	0.00255	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00127	0.00249	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00127	0.00248	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00124	0.00242	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00123	0.0024	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00115	0.00226	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GNRH1—adrenal gland cancer	0.00114	0.00223	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0011	0.00216	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00109	0.00214	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—POMC—adrenal gland cancer	0.00109	0.00213	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CDC42—adrenal gland cancer	0.00105	0.00205	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SPRY2—adrenal gland cancer	0.00104	0.00204	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00103	0.00201	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TSHR—adrenal gland cancer	0.00102	0.00199	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—GNAS—adrenal gland cancer	0.001	0.00196	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000972	0.0019	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	0.000969	0.00189	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000958	0.00187	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MEN1—adrenal gland cancer	0.000957	0.00187	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000947	0.00185	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000916	0.00179	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000911	0.00178	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00087	0.0017	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000867	0.00169	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000851	0.00166	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TSHR—adrenal gland cancer	0.000844	0.00165	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000842	0.00165	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000832	0.00163	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000813	0.00159	CbGpPWpGaD
Alfuzosin—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000813	0.00159	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MEN1—adrenal gland cancer	0.000794	0.00155	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000773	0.00151	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00077	0.0015	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.00075	0.00147	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—POMC—adrenal gland cancer	0.000743	0.00145	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000739	0.00144	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PRKACA—adrenal gland cancer	0.00073	0.00143	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000727	0.00142	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000705	0.00138	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—POMC—adrenal gland cancer	0.000675	0.00132	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CDC42—adrenal gland cancer	0.000619	0.00121	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000617	0.00121	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000606	0.00118	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF2—adrenal gland cancer	0.000597	0.00117	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000592	0.00116	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000577	0.00113	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	0.00056	0.00109	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000548	0.00107	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000538	0.00105	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000514	0.00101	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000497	0.000972	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	0.000497	0.000971	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000496	0.000969	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000491	0.00096	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000479	0.000937	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000469	0.000916	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000469	0.000916	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000457	0.000893	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.00044	0.000861	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000436	0.000853	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	0.000432	0.000845	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000426	0.000832	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	0.000412	0.000806	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	0.000399	0.000779	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000394	0.000769	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000381	0.000746	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000366	0.000716	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	0.000359	0.000701	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000349	0.000683	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	0.000331	0.000647	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000327	0.000639	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000319	0.000623	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000317	0.000619	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.000294	0.000574	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.00029	0.000567	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000284	0.000556	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000281	0.00055	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000255	0.000498	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000236	0.000461	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000225	0.000441	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00021	0.00041	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000207	0.000404	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000203	0.000396	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	0.000189	0.00037	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000187	0.000366	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	0.000166	0.000325	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	0.000157	0.000307	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	0.000139	0.000273	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000139	0.000272	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000111	0.000217	CbGpPWpGaD
